- Bilastine Impurity 10
-
- $0.00 / 10mg
-
2026-03-12
- CAS:202189-77-3
- Min. Order: 10mg
- Purity: 98%
- Supply Ability: 500mg
|
| | 2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole Basic information |
| Product Name: | 2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole | | Synonyms: | 2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole;Bilastine impurity E;2-(1-(4-(2-(4,4-dimethyl-4,5-dihydrooxazol-2-y l)propan-2-yl)phenethyl)piperidin-4-yl)-1-(2-e thoxyethyl)-1H-benzo[d]imidazole;1H-Benzimidazole, 2-[1-[2-[4-[1-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-1-methylethyl]phenyl]ethyl]-4-piperidinyl]-1-(2-ethoxyethyl)-;4,5-Dihydrooxazole Bilastine;Bilastine Impurity 33;2-(2-(4-(2-(4-(1-(2-Ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazo;2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo [d] imidazole-2-yl) piperidin-1-yl) ethyl) phenyl) propan-2-yl) -4,4-dimethyl-4,5-dihydrooxazole. | | CAS: | 202189-77-3 | | MF: | C32H44N4O2 | | MW: | 516.72 | | EINECS: | 813-963-4 | | Product Categories: | | | Mol File: | 202189-77-3.mol | ![2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole Structure](CAS/20180703/GIF/202189-77-3.gif) |
| | 2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole Chemical Properties |
| Boiling point | 645.7±55.0 °C(Predicted) | | density | 1.13±0.1 g/cm3(Predicted) | | vapor pressure | 0Pa at 25℃ | | form | Solid | | pka | 8.73±0.10(Predicted) |
| | 2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole Usage And Synthesis |
| Uses | 4,5-Dihydrooxazole Bilastine is an impurity of Bilastine (B385000), which is a novel, nonsedating H1-antihistamine developed for symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria. |
| | 2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole Preparation Products And Raw materials |
|